Moreover, THBS2 + CAFs were closer to resistant malignant cells in spatial distance and had more interactions with resistant cells, suggesting that THBS2 + CAFs facilitated CRC oxaliplatin resistance. This evidence concerns the gene THBS2 and colorectal carcinoma.